Price T Rowe Associates Inc Keros Therapeutics, Inc. Transaction History

Price T Rowe Associates Inc

$883 Billion
Q2 2025

A detailed history of Price T Rowe Associates Inc transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 48,415 shares of KROS stock, worth $663,769. This represents 0.0% of its overall portfolio holdings.

Number of Shares

48,415

Previous 43,227 12.0%

Holding current value

$663,769

Previous $441,000 46.71%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$9.55 - $15.11 $49,545 - $78,390	5,188 Added 12.0%	48,415 $647,000
Q1 2025 May 14, 2025	SELL	$10.15 - $16.1 $8.79 Million - $14 Million	-866,480 Reduced 95.25%	43,227 $441,000
Q4 2024 Feb 14, 2025	SELL	$15.64 - $70.0 $9.46 Million - $42.3 Million	-604,798 Reduced 39.93%	909,707 $14.4 Million
Q3 2024 Nov 14, 2024	BUY	$41.68 - $58.07 $13.6 Million - $19 Million	326,595 Added 27.49%	1,514,505 $87.9 Million
Q2 2024 Aug 14, 2024	SELL	$44.58 - $66.89 $1.36 Million - $2.05 Million	-30,594 Reduced 2.51%	1,187,910 $54.3 Million
Q1 2024 May 15, 2024	BUY	$41.26 - $70.48 $7.29 Million - $12.5 Million	176,803 Added 16.97%	1,218,504 $80.7 Million
Q4 2023 Feb 14, 2024	SELL	$27.12 - $41.05 $6.12 Million - $9.26 Million	-225,531 Reduced 17.8%	1,041,701 $41.4 Million
Q3 2023 Nov 14, 2023	SELL	$31.57 - $43.02 $98,782 - $134,609	-3,129 Reduced 0.25%	1,267,232 $40.4 Million
Q2 2023 Aug 14, 2023	BUY	$37.26 - $51.01 $4.39 Million - $6.01 Million	117,845 Added 10.23%	1,270,361 $51 Million
Q1 2023 May 15, 2023	BUY	$41.44 - $59.32 $22 Million - $31.5 Million	531,327 Added 85.53%	1,152,516 $49.2 Million
Q4 2022 Feb 14, 2023	BUY	$39.45 - $51.77 $24.1 Million - $31.7 Million	611,459 Added 6284.27%	621,189 $29.8 Million
Q3 2022 Nov 14, 2022	BUY	$27.8 - $40.12 $270,494 - $390,367	9,730 New	9,730 $367,000
Q2 2022 Aug 15, 2022	SELL	$26.03 - $67.04 $117,265 - $302,015	-4,505 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$42.12 - $59.36 $86,851 - $122,400	-2,062 Reduced 31.4%	4,505 $245,000
Q4 2021 Feb 14, 2022	BUY	$36.95 - $62.89 $242,650 - $412,998	6,567 New	6,567 $384,000

Others Institutions Holding KROS

# of Institutions

156

Shares Held

38.6M

Call Options Held

834K

Put Options Held

969K

View Full List

About Keros Therapeutics, Inc.

Ticker KROS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,757,000
Market Cap $353M
Description
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...

More about KROS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Keros Therapeutics, Inc. Transaction History